FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
September 15, 2023 1 min read Source/Disclosures Published by: Disclosures: Chen reports no relevant financial disclosures. Please see the study
Read MoreChris Rondeau, CEO of Planet Fitness Adam Jeffery | CNBC In a move that stunned investors and employees alike, Planet
Read MoreSeptember 15, 2023 1 min read Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO
Read MoreThe California Legislature passed a pair of bills greenlighting Gov. Gavin Newsom’s campaign to build 10,000 new beds and housing
Read MoreAmong the multi-system effects observed in patients with COVID-19, neurologic manifestations have been noted in more than 82% of those
Read MoreSACRAMENTO, Calif. — A sweeping agreement between labor and the health industry would gradually raise the minimum wage for hundreds
Read MoreSeptember 14, 2023 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read MorePharmacist Ani Martirosyan administers an immunization to a patient at a CVS on Tuesday, Sept. 12, 2023 in Glendale, CA.
Read MoreThe Centers for Disease Control and Prevention recommends new covid-19 booster vaccines for all — but many who need them
Read MoreSYRACUSE, Neb. — Many rural communities like this one face a health care dilemma: Is it better to have a
Read More